
Tazlive 80mg Tablet
Marketer
Allysia Lifesciences Pvt Ltd
Salt Composition
Telmisartan (80mg)
Overview Tazlive 80mg Tablet
CardioGuard 80mg tablets manage hypertension and congestive heart failure, mitigating the risk of stroke and myocardial infarction. Its efficacy extends to preserving renal function in diabetic patients. This medication can be administered independently or concurrently with other treatments, at any time of day, with or without food; consistent daily dosing is crucial for optimal results. Continued use, even with controlled blood pressure or asymptomatic conditions, is vital; discontinuation may exacerbate the underlying illness. Generally well-tolerated for long-term use, it may cause hypotension in some individuals. Report any adverse effects; dosage adjustment or alternative medication may be necessary. Prior to commencing treatment, disclose any hepatic or renal impairment, pregnancy, or breastfeeding. Regular monitoring of renal function, blood pressure, and serum potassium levels may be implemented by your physician. Lifestyle modifications – including exercise, weight management, smoking cessation, moderated alcohol consumption, and a reduced sodium diet (as advised) – complement this therapy.
Primary Ingredients of Tazlive 80mg Tablet
There is no text provided to rephrase.
Uses of Tazlive 80mg Tablet
Managing elevated blood pressure | Cardiac insufficiency treatment | Pyrexia | Cardiovascular event prophylaxis
Major Benefits of Tazlive 80mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 80mg Tazlive tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistency is key—take it at the same time each day.
Common Side effects of Tazlive 80mg Tablet:
- Diarrhea
- Upper respiratory tract infection
- Back pain
- Sinus inflammation
- Skin ulcer
- Intermittent claudication
How to use Tazlive 80mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tazlive 80mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Tazlive 80mg Tablet works:
Hypertensin control is achieved with Tazlive 80mg, an angiotensin receptor blocker. This medication works by inhibiting a vasoconstricting substance, thereby promoting vasodilation. Consequently, blood pressure is reduced, improving blood flow throughout the body and optimizing cardiac function.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Tazlive 80mg tablets.
PregnancyCONSULT YOUR DOCTOR
Using Tazlive 80mg tablets during pregnancy poses a confirmed risk to the fetus, and should be avoided. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Tazlive 80mg Tablet for breastfeeding mothers is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, blurred vision, or dizziness after taking an 80mg Tazlive tablet, as these side effects can impair alertness.
KidneyCAUTION
Patients with severe kidney impairment should use Tazlive 80mg Tablets cautiously, as dosage modification may be necessary. Consult your physician for guidance. Disclosure of pre-existing kidney disease is crucial. Your doctor may recommend routine monitoring of blood pressure, creatinine, and potassium levels during treatment.
LiverCAUTION
Patients with liver impairment should use 80mg Tazlive tablets cautiously, potentially requiring dose modification under medical supervision. Tazlive 80mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Tazlive 80mg Tablet :
Omit any missed Tazlive 80mg Tablet dose and resume your usual dosing regimen; avoid taking a double dose.
Facts to Know About Tazlive 80mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Benzimiidazole-based compound |
| Potential for Dependence | None. |
| Type of Treatment | HEART |
